Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity.
Suppan C, Posch F, Mueller HD, Mischitz N, Steiner D, Klocker EV, Setaffy L, Bargfrieder U, Hammer R, Hauser H, Jost PJ, Dandachi N, Lax S, Balic M. Suppan C, et al. Among authors: jost pj. Cancers (Basel). 2021 May 20;13(10):2492. doi: 10.3390/cancers13102492. Cancers (Basel). 2021. PMID: 34065332 Free PMC article.
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Riedl JM, Schwarzenbacher E, Moik F, Horvath L, Gantschnigg A, Renneberg F, Posch F, Barth DA, Stotz M, Pichler M, Hatzl S, Fandler-Höfler S, Gressenberger P, Gary T, Jost PJ, Greil R, Ay C, Djanani A, Gerger A, Schlick K. Riedl JM, et al. Among authors: jost pj. Thromb Haemost. 2022 Apr;122(4):633-645. doi: 10.1055/a-1548-4847. Epub 2021 Aug 24. Thromb Haemost. 2022. PMID: 34255340
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Müller M, Posch F, Kiem D, Barth D, Horvath L, Stotz M, Schaberl-Moser R, Pichler M, Greil R, Jost PJ, Seeber A, Amann A, Schlick K, Gerger A, Riedl JM. Müller M, et al. Among authors: jost pj. Ther Adv Med Oncol. 2021 Sep 30;13:17588359211039930. doi: 10.1177/17588359211039930. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34616490 Free PMC article.
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Suppan C, Graf R, Jahn S, Zhou Q, Klocker EV, Bartsch R, Terbuch A, Kashofer K, Regitnig P, Lindenmann J, Posch F, Gerritsmann H, Jost PJ, Heitzer E, Dandachi N, Balic M. Suppan C, et al. Among authors: jost pj. Br J Cancer. 2022 Feb;126(3):456-463. doi: 10.1038/s41416-021-01601-9. Epub 2021 Nov 9. Br J Cancer. 2022. PMID: 34754095 Free PMC article.
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Barth DA, Stanzer S, Spiegelberg J, Bauernhofer T, Absenger G, Posch F, Lipp R, Halm M, Szkandera J, Balic M, Gerger A, Smolle MA, Hutterer GC, Klec C, Jost PJ, Kargl J, Stradner M, Pichler M. Barth DA, et al. Among authors: jost pj. Cancer Med. 2022 Aug;11(16):3074-3083. doi: 10.1002/cam4.4675. Epub 2022 Mar 16. Cancer Med. 2022. PMID: 35297215 Free PMC article.
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Barth DA, Stanzer S, Spiegelberg JA, Bauernhofer T, Absenger G, Szkandera J, Gerger A, Smolle MA, Hutterer GC, Ahyai SA, Madl T, Posch F, Riedl JM, Klec C, Jost PJ, Kargl J, Stradner MH, Pichler M. Barth DA, et al. Among authors: jost pj. Front Immunol. 2022 Apr 1;13:840207. doi: 10.3389/fimmu.2022.840207. eCollection 2022. Front Immunol. 2022. PMID: 35432362 Free PMC article.
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Maisel F, Smolle MA, Mollnar S, Riedl JM, Barth DA, Seles M, Terbuch A, Rossmann CH, Eisner F, Mannweiler S, Hutterer G, Zigeuner R, Pummer K, Smolle-Jüttner FM, Lindenmann J, Stotz M, Gerger A, Jost PJ, Bauernhofer T, Pichler M, Posch F. Maisel F, et al. Among authors: jost pj. Clin Genitourin Cancer. 2022 Aug;20(4):344-353. doi: 10.1016/j.clgc.2022.03.010. Epub 2022 Mar 24. Clin Genitourin Cancer. 2022. PMID: 35443915 Free article.
114 results